These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16367740

  • 41. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
    Zhao HP, Sun JF, Li N, Sun Y, Wang Y, Qiu HJ.
    Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):158-66. PubMed ID: 19411115
    [Abstract] [Full Text] [Related]

  • 42. Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein.
    Zhang H.
    Hepatobiliary Pancreat Dis Int; 2003 Aug 15; 2(3):374-82. PubMed ID: 14599943
    [Abstract] [Full Text] [Related]

  • 43. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y, Xiong X, Liu X, Li J, Wen Y, Chen Y, Dai Q, Cao Z, Yu W.
    Mol Immunol; 2006 Feb 15; 43(5):436-42. PubMed ID: 16337486
    [Abstract] [Full Text] [Related]

  • 44. Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene.
    Sominskaya I, Alekseeva E, Skrastina D, Mokhonov V, Starodubova E, Jansons J, Levi M, Prilipov A, Kozlovska T, Smirnov V, Pumpens P, Isaguliants MG.
    Mol Immunol; 2006 May 15; 43(12):1941-52. PubMed ID: 16442623
    [Abstract] [Full Text] [Related]

  • 45. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial.
    Alvarez-Lajonchere L, Shoukry NH, Grá B, Amador-Cañizares Y, Helle F, Bédard N, Guerra I, Drouin C, Dubuisson J, González-Horta EE, Martínez G, Marante J, Cinza Z, Castellanos M, Dueñas-Carrera S.
    J Viral Hepat; 2009 Mar 15; 16(3):156-67. PubMed ID: 19017255
    [Abstract] [Full Text] [Related]

  • 46. Nucleic acid vaccines against hepatitis viruses.
    Howard CR, Gray L, D'Mello F, Christopher J, Craske J.
    Dev Biol Stand; 1998 Mar 15; 92():157-62. PubMed ID: 9554270
    [Abstract] [Full Text] [Related]

  • 47. Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization.
    Li P, Wan Q, Feng Y, Liu M, Wu J, Chen X, Zhang XL.
    Vaccine; 2007 Feb 09; 25(8):1544-51. PubMed ID: 17055129
    [Abstract] [Full Text] [Related]

  • 48. Antigenic relevance of F protein in chronic hepatitis C virus infection.
    Komurian-Pradel F, Rajoharison A, Berland JL, Khouri V, Perret M, Van Roosmalen M, Pol S, Negro F, Paranhos-Baccalà G.
    Hepatology; 2004 Oct 09; 40(4):900-9. PubMed ID: 15382175
    [Abstract] [Full Text] [Related]

  • 49. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.
    Jiang Y, Xiao S, Fang L, Yu X, Song Y, Niu C, Chen H.
    Vaccine; 2006 Apr 05; 24(15):2869-79. PubMed ID: 16446016
    [Abstract] [Full Text] [Related]

  • 50. [Immune response and protective efficacy in BALB/c mice induced by DNA vaccine encoding immunogenic protein of Legionella pneumophila].
    Yang ZW, Chen JP, Wang T, Tian Y.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar 05; 23(3):209-12. PubMed ID: 17343784
    [Abstract] [Full Text] [Related]

  • 51. [Immune responses induced by the suicidal DNA vaccines co-expressing the GP5 protein of PRRSV and the E2 protein of CSFV in mice].
    Sun J, Zhao H, Li N, Sun Y, Xi Z, Zhou Y, Wang Y, Qi Q, Lu C, Qiu H.
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct 05; 24(10):1714-22. PubMed ID: 19149182
    [Abstract] [Full Text] [Related]

  • 52. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.
    Murata K, Lechmann M, Qiao M, Gunji T, Alter HJ, Liang TJ.
    Proc Natl Acad Sci U S A; 2003 May 27; 100(11):6753-8. PubMed ID: 12748380
    [Abstract] [Full Text] [Related]

  • 53. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A, Zahedifard F, Taghikhani M, Rafati S.
    Vaccine; 2008 Jun 19; 26(26):3362-70. PubMed ID: 18471945
    [Abstract] [Full Text] [Related]

  • 54. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S, Staib C, Lasarte JJ, Sutter G, Adler H.
    J Gene Med; 2008 Feb 19; 10(2):177-86. PubMed ID: 18076128
    [Abstract] [Full Text] [Related]

  • 55. Effect of immunological adjuvants: GM-CSF (granulocyte-monocyte colony stimulating factor) and IL-23 (interleukin-23) on immune responses generated against hepatitis C virus core DNA vaccine.
    Hartoonian C, Ebtekar M, Soleimanjahi H, Karami A, Mahdavi M, Rastgoo N, Azadmanesh K.
    Cytokine; 2009 Apr 19; 46(1):43-50. PubMed ID: 19278866
    [Abstract] [Full Text] [Related]

  • 56. A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2.
    Tedeschi V, Akatsuka T, Shih JW, Battegay M, Feinstone SM.
    Hepatology; 1997 Feb 19; 25(2):459-62. PubMed ID: 9021964
    [Abstract] [Full Text] [Related]

  • 57. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens.
    Kuzushita N, Gregory SH, Monti NA, Carlson R, Gehring S, Wands JR.
    Gastroenterology; 2006 Feb 19; 130(2):453-64. PubMed ID: 16472599
    [Abstract] [Full Text] [Related]

  • 58. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B, Fernandez-Pacheco P, Ganges L, Domenech N, Fernandez-Borges N, Sobrino F, Rodríguez F.
    Vaccine; 2006 May 01; 24(18):3889-99. PubMed ID: 16563575
    [Abstract] [Full Text] [Related]

  • 59. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A.
    Yu YZ, Zhang SM, Sun ZW, Wang S, Yu WY.
    Vaccine; 2007 Dec 17; 25(52):8843-50. PubMed ID: 18022294
    [Abstract] [Full Text] [Related]

  • 60. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W, Ren L, Jin N.
    J Virol Methods; 2007 Dec 17; 146(1-2):266-73. PubMed ID: 17868910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.